-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
- Nurix Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending August 31, 2024 was 72.8M shares, a 33.8% increase year-over-year.
- Nurix Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 54.3M shares, a 11.8% increase from 2022.
- Nurix Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.6M shares, a 13.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)